chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pharyngeal swelling, Pyrexia, Respiratory syncytial virus test
Clinical narrative: Hip and back muscle pain; bedridden; nausea; Sore arm injection site ,could not lift arm; Swollen Throat; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever) and CHILLS (chills) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Swollen Throat), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm). On 07-Apr-2021, the patient experienced PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden) and NAUSEA (nausea). At the time of the report, PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 99.2 (High) 99.2. On 07-Apr-2021, Influenza A virus test: (Negative) Negative. On 07-Apr-2021, Influenza B virus test: (Negative) Negative. On 07-Apr-2021, Respiratory syncytial virus test: (Negative) Negative. On 07-Apr-2021, SARS-CoV-2 test: (Negative) Negative. On 07-Apr-2021, Streptococcus test: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Additional information received on 20-May-2021 contains no new information.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Streptococcus test, Vaccination site pain
Clinical narrative: Hip and back muscle pain; bedridden; nausea; Sore arm injection site ,could not lift arm; Swollen Throat; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever) and CHILLS (chills) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Swollen Throat), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm). On 07-Apr-2021, the patient experienced PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden) and NAUSEA (nausea). At the time of the report, PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 99.2 (High) 99.2. On 07-Apr-2021, Influenza A virus test: (Negative) Negative. On 07-Apr-2021, Influenza B virus test: (Negative) Negative. On 07-Apr-2021, Respiratory syncytial virus test: (Negative) Negative. On 07-Apr-2021, SARS-CoV-2 test: (Negative) Negative. On 07-Apr-2021, Streptococcus test: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Additional information received on 20-May-2021 contains no new information.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Parosmia
Clinical narrative: cannot smell; cannot taste; began smelling "smokiness"; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (began smelling "smokiness"), ANOSMIA (cannot smell) and AGEUSIA (cannot taste) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for an unknown indication.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced PAROSMIA (began smelling "smokiness"). On 08-Apr-2021, the patient experienced ANOSMIA (cannot smell) and AGEUSIA (cannot taste). On 08-Apr-2021, PAROSMIA (began smelling "smokiness") had resolved. At the time of the report, ANOSMIA (cannot smell) and AGEUSIA (cannot taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug information was not provided. Treatment was unknown.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Neck mass, Ultrasound scan
Clinical narrative: Lumps return on neck and were larger; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (Lumps return on neck and were larger) and CHILLS (Chills) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced NECK MASS (Lumps return on neck and were larger) and CHILLS (Chills). On 29-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, NECK MASS (Lumps return on neck and were larger) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Ultrasound scan: normal normal (normal) No biopsy, Advised to wait two weeks before ultrasound.         No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable. 15 Jan 2021 lab work only. No biopsy, Advised to wait two weeks before ultrasound as per caller.   This case was linked to MOD-2021-020597 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up information was received on 07 May 2021 which included no new information.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. The patient's last menstrual period was on 07-Sep-2020 and the estimated date of delivery was 21-Jun-2021. On 08-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  On 08-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Internal review on 20JUL2021 resulted in updates to pregnancy details.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Fatigue, Vaccination site pain
Clinical narrative: active covid infection; Soreness of arm at injection site; Joint pains; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (active covid infection) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (active covid infection) (seriousness criterion medically significant), VACCINATION SITE PAIN (Soreness of arm at injection site), ARTHRALGIA (Joint pains) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COVID-19 (active covid infection), VACCINATION SITE PAIN (Soreness of arm at injection site), ARTHRALGIA (Joint pains) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Additional Information received included no new significant information.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. However, the mRNA-1273 does not contain a virus capable of causing infection and with the occurrence of COVID-19 infection after vaccination, the causality of this event is assessed as not applicable.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: liquid running down her arm from the needle to her elbow.; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (liquid running down her arm from the needle to her elbow.) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (liquid running down her arm from the needle to her elbow.). At the time of the report, UNDERDOSE (liquid running down her arm from the needle to her elbow.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided  No treatment medication was provided
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Feeling abnormal, Nasal congestion, Oropharyngeal pain, Pain
Clinical narrative: sore throat; running nose; stuffed up; achy all over; feels like crap; ear aches in both ears; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over) and FEELING ABNORMAL (feels like crap) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over), FEELING ABNORMAL (feels like crap), EAR PAIN (ear aches in both ears) and PYREXIA (slight fever). At the time of the report, OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over), FEELING ABNORMAL (feels like crap), EAR PAIN (ear aches in both ears) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: sore throat; running nose; stuffed up; achy all over; feels like crap; ear aches in both ears; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over) and FEELING ABNORMAL (feels like crap) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over), FEELING ABNORMAL (feels like crap), EAR PAIN (ear aches in both ears) and PYREXIA (slight fever). At the time of the report, OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (running nose), NASAL CONGESTION (stuffed up), PAIN (achy all over), FEELING ABNORMAL (feels like crap), EAR PAIN (ear aches in both ears) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: This morning she started with headache; She had body aches all day long; she had chills all day long next day after receiving 2nd dose; She thinks she had a low grade fever next day after receiving vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose), PYREXIA (She thinks she had a low grade fever next day after receiving vaccine) and HEADACHE (This morning she started with headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose) and PYREXIA (She thinks she had a low grade fever next day after receiving vaccine). On 09-Apr-2021, the patient experienced HEADACHE (This morning she started with headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (She had body aches all day long), CHILLS (she had chills all day long next day after receiving 2nd dose), PYREXIA (She thinks she had a low grade fever next day after receiving vaccine) and HEADACHE (This morning she started with headache) outcome was unknown. Reporter did not allow further contact
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash, Swollen tongue
Clinical narrative: Allergy to the vaccine; Eruptions and lumps on his chest, stomach area and wrist and hands; Swollen tongue; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE, HYPERSENSITIVITY, and RASH in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy. Concomitant products included ASPIRIN for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWOLLEN TONGUE, HYPERSENSITIVITY, and RASH. At the time of the report, SWOLLEN TONGUE and RASH had resolved and HYPERSENSITIVITY outcome was unknown. recovered with allergy pills.           It was reported that the patient was deemed to have allergies to the vaccine (having visited an allergist). He had swollen tongue (twice), eruptions and lumps on his chest, stomach area, wrist, and hands. It disappeared the next day (with intake of allergy pills).  Treatment medication included allergy pills (unspecified).   Reporter did not allow further contact.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Positive covid-19 test result; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive covid-19 test result) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 immunisation.     The patient's past medical history included No adverse effect.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive covid-19 test result). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive covid-19 test result) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment details were provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Limb discomfort, Pain, Pyrexia
Clinical narrative: aches and pains; headache and chills; headache and chills; Feverish; had just a little sore arm after the first; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (had just a little sore arm after the first ), HEADACHE (headache and chills), CHILLS (headache and chills), PYREXIA (Feverish) and PAIN (aches and pains) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 21-Jan-2021, the patient experienced LIMB DISCOMFORT (had just a little sore arm after the first ). On 20-Feb-2021, the patient experienced HEADACHE (headache and chills). 20-Feb-2021, the patient experienced CHILLS (headache and chills) and PYREXIA (Feverish). On 21-Feb-2021, the patient experienced PAIN (aches and pains). The patient was treated with PARACETAMOL (TYLENOL) for Feverish and General body pain, at an unspecified dose and frequency. On 21-Feb-2021, HEADACHE (headache and chills), CHILLS (headache and chills), PYREXIA (Feverish) and PAIN (aches and pains) had resolved. At the time of the report, LIMB DISCOMFORT (had just a little sore arm after the first ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient stated he has been shrinking, started before the vaccination Patient was treated with Tylenol for pains, aches and fever Patient stated that he and his wife has same providers   This case was linked to MOD-2021-073474 (Patient Link).   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Swelling face
Clinical narrative: Shingles right side of face; Shingles right eye; swelling left side of face; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles right side of face), HERPES ZOSTER (Shingles right eye) and SWELLING FACE (swelling left side of face) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A29A) for COVID-19 vaccination.     No medical history information provided.  Concomitant products included VALACYCLOVIR [VALACICLOVIR] and PREDNISONE for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced HERPES ZOSTER (Shingles right side of face), HERPES ZOSTER (Shingles right eye) and SWELLING FACE (swelling left side of face). At the time of the report, HERPES ZOSTER (Shingles right side of face), HERPES ZOSTER (Shingles right eye) and SWELLING FACE (swelling left side of face) outcome was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site swelling
Clinical narrative: intermittent chills; injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (intermittent chills) and INJECTION SITE SWELLING (injection site swollen) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 02-Apr-2021, the patient experienced CHILLS (intermittent chills) and INJECTION SITE SWELLING (injection site swollen). At the time of the report, CHILLS (intermittent chills) and INJECTION SITE SWELLING (injection site swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided Treatment for the events, were not provided
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Delayed the second dose because of the side effect; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Delayed the second dose because of the side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided. Patient was due for his second dose on 01Apr2021, but they delayed it because of the side effect from first dose Bell's palsy. The reporter updated that the patient is still recovering and has marginal improvement.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No medical history was reported.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (fever). At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a chemo treatment starting 03Mar2021 with a pump until 05Mar2021. Patient was in the hospital 06Mar2021 until 09Mar2021.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: injecting vaccine to patient less than 18; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injecting vaccine to patient less than 18) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injecting vaccine to patient less than 18). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injecting vaccine to patient less than 18) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injecting vaccine to patient less than 18) to be not applicable.    No concomitant medications were provided  No treatment medications were provided
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: light soreness in the arm where he received the Moderna COVID-19 injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (light soreness in the arm where he received the Moderna COVID-19 injection) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (light soreness in the arm where he received the Moderna COVID-19 injection). At the time of the report, PAIN IN EXTREMITY (light soreness in the arm where he received the Moderna COVID-19 injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported.   This case was linked to MOD21-072543, MOD21-072518 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Chills, Decreased appetite, Dyskinesia
Clinical narrative: leg swelling; anxious; body jerking; sore arm; chills; difficulty breathing; weak; lack of appetite; red face; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Sclerosis multiple. Concomitant products included ESTRADIOL, LATANOPROST, TIMOLOL, LATANOPROST, MONTELUKAST, ROSUVASTATIN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE (HYDROCHOROTHIAZIDE), GABAPENTIN, TEMAZEPAM, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D), FISH OIL, UBIDECARENONE (COQ 10), CENTRUM SILVER +50, CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), PARACETAMOL (TYLENOL), PLANTAGO OVATA (METAMUCIL CITRON), IBUPROFEN (ADVIL 12 HOUR) and OCRELIZUMAB (OCREVUS) for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm), CHILLS (chills), DYSPNOEA (difficulty breathing), ASTHENIA (weak), DECREASED APPETITE (lack of appetite) and ERYTHEMA (red face). At the time of the report, PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm), CHILLS (chills), DYSPNOEA (difficulty breathing), ASTHENIA (weak), DECREASED APPETITE (lack of appetite) and ERYTHEMA (red face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication included.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: leg swelling; anxious; body jerking; sore arm; chills; difficulty breathing; weak; lack of appetite; red face; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Sclerosis multiple. Concomitant products included ESTRADIOL, LATANOPROST, TIMOLOL, LATANOPROST, MONTELUKAST, ROSUVASTATIN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE (HYDROCHOROTHIAZIDE), GABAPENTIN, TEMAZEPAM, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D), FISH OIL, UBIDECARENONE (COQ 10), CENTRUM SILVER +50, CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), PARACETAMOL (TYLENOL), PLANTAGO OVATA (METAMUCIL CITRON), IBUPROFEN (ADVIL 12 HOUR) and OCRELIZUMAB (OCREVUS) for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm), CHILLS (chills), DYSPNOEA (difficulty breathing), ASTHENIA (weak), DECREASED APPETITE (lack of appetite) and ERYTHEMA (red face). At the time of the report, PERIPHERAL SWELLING (leg swelling), ANXIETY (anxious), DYSKINESIA (body jerking), PAIN IN EXTREMITY (sore arm), CHILLS (chills), DYSPNOEA (difficulty breathing), ASTHENIA (weak), DECREASED APPETITE (lack of appetite) and ERYTHEMA (red face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication included.   Reporter did not allow further contact
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever 101 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101 F) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever 101 F). At the time of the report, PYREXIA (fever 101 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 F.         No concomitant medication was reported. No treatment medication was reported.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Headache, Nausea, Pain
Clinical narrative: Dizziness; Nausea.; circulation issues; Mild cough; wheezing; Headache; pain to left arm radiating to side of neck; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL VASCULAR DISORDER (circulation issues), COUGH (Mild cough), WHEEZING (wheezing), HEADACHE (Headache) and PAIN (pain to left arm radiating to side of neck) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history were reported.  Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PERIPHERAL VASCULAR DISORDER (circulation issues), COUGH (Mild cough), WHEEZING (wheezing), HEADACHE (Headache) and PAIN (pain to left arm radiating to side of neck). On 09-Apr-2021, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea.). The patient was treated with PARACETAMOL (TYNELOL) at an unspecified dose and frequency. On 09-Apr-2021, COUGH (Mild cough) and WHEEZING (wheezing) had resolved. At the time of the report, PERIPHERAL VASCULAR DISORDER (circulation issues) and PAIN (pain to left arm radiating to side of neck) outcome was unknown and HEADACHE (Headache), DIZZINESS (Dizziness) and NAUSEA (Nausea.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral vascular disorder, Wheezing
Clinical narrative: Dizziness; Nausea.; circulation issues; Mild cough; wheezing; Headache; pain to left arm radiating to side of neck; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL VASCULAR DISORDER (circulation issues), COUGH (Mild cough), WHEEZING (wheezing), HEADACHE (Headache) and PAIN (pain to left arm radiating to side of neck) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history were reported.  Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PERIPHERAL VASCULAR DISORDER (circulation issues), COUGH (Mild cough), WHEEZING (wheezing), HEADACHE (Headache) and PAIN (pain to left arm radiating to side of neck). On 09-Apr-2021, the patient experienced DIZZINESS (Dizziness) and NAUSEA (Nausea.). The patient was treated with PARACETAMOL (TYNELOL) at an unspecified dose and frequency. On 09-Apr-2021, COUGH (Mild cough) and WHEEZING (wheezing) had resolved. At the time of the report, PERIPHERAL VASCULAR DISORDER (circulation issues) and PAIN (pain to left arm radiating to side of neck) outcome was unknown and HEADACHE (Headache), DIZZINESS (Dizziness) and NAUSEA (Nausea.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site swelling, Vaccination site warmth
Clinical narrative: arm is warm at the site of injection; fever; chills; arm is swollen at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm is warm at the site of injection), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE SWELLING (arm is swollen at the site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE WARMTH (arm is warm at the site of injection), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE SWELLING (arm is swollen at the site of injection). At the time of the report, VACCINATION SITE WARMTH (arm is warm at the site of injection), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE SWELLING (arm is swollen at the site of injection) outcome was unknown.            Treatment product- Tylenol
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Fatigue, Vomiting
Clinical narrative: diarrhea; cough; vomiting; generalized tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), COUGH (cough), VOMITING (vomiting) and FATIGUE (generalized tiredness) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21AA) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIARRHOEA (diarrhea), COUGH (cough), VOMITING (vomiting) and FATIGUE (generalized tiredness). At the time of the report, DIARRHOEA (diarrhea), COUGH (cough), VOMITING (vomiting) and FATIGUE (generalized tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment medication was reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: fever; headache; aches and pains; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), HEADACHE (headache), MYALGIA (aches and pains) and CHILLS (chills) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PYREXIA (fever), HEADACHE (headache), MYALGIA (aches and pains) and CHILLS (chills). On 21-Feb-2021, PYREXIA (fever), HEADACHE (headache), MYALGIA (aches and pains) and CHILLS (chills) had resolved.            Treatment medicine included Acetaminophen. Concomitant medication not provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of arthralgia (soreness) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concomitant products included Actemra (tocilizumab) for an unknown indication. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced arthralgia (soreness). At the time of the report, arthralgia (soreness) outcome: unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest hurt) and DYSPNOEA (trouble breathing) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 026B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced CHEST PAIN (chest hurt) and DYSPNOEA (trouble breathing). On 12-Mar-2021, CHEST PAIN (chest hurt) and DYSPNOEA (trouble breathing) had resolved. Not Provided. Patient received the vaccines in the Left Non-Dominant arm. Concomitant product use was not provided. Action taken with mRNA in the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort
Clinical narrative: Ears felt hot for a couple of hours after vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (Ears felt hot for a couple of hours after vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR DISCOMFORT (Ears felt hot for a couple of hours after vaccine administered). At the time of the report, EAR DISCOMFORT (Ears felt hot for a couple of hours after vaccine administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Crying, Dyspnoea, Headache, Pain, Pyrexia
Clinical narrative: it starded hurting a lot; Had such strong pain that it even made her cry; cannot breathe; lots of fever; a very strong headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (lots of fever), HEADACHE (a very strong headache), DYSPNOEA (cannot breathe), PAIN (it starded hurting a lot) and CRYING (Had such strong pain that it even made her cry) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B12LA) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported.).    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced PYREXIA (lots of fever) and HEADACHE (a very strong headache). On 08-Apr-2021, the patient experienced DYSPNOEA (cannot breathe). On an unknown date, the patient experienced PAIN (it starded hurting a lot) and CRYING (Had such strong pain that it even made her cry). At the time of the report, PYREXIA (lots of fever), HEADACHE (a very strong headache), DYSPNOEA (cannot breathe), PAIN (it starded hurting a lot) and CRYING (Had such strong pain that it even made her cry) outcome was unknown.            Treatment details included Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of taste disorder (changes in taste) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for an unknown indication. The patient's past medical history included no adverse event. On Jan 1, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; unspecified dose. On Jan 3, 2021, patient experienced taste disorder (changes in taste). At the time of the report, taste disorder (changes in taste) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Reporter did not allow further contact.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal, Oropharyngeal pain
Clinical narrative: Sore throat; Dizzy; Weak; "Feels like everything rushed to my head"; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), DIZZINESS (Dizzy), ASTHENIA (Weak) and FEELING ABNORMAL ("Feels like everything rushed to my head") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat), DIZZINESS (Dizzy), ASTHENIA (Weak) and FEELING ABNORMAL ("Feels like everything rushed to my head"). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), DIZZINESS (Dizzy), ASTHENIA (Weak) and FEELING ABNORMAL ("Feels like everything rushed to my head") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Swelling face
Clinical narrative: facial swelling; unspecified allergy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (facial swelling) and HYPERSENSITIVITY (unspecified allergy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced SWELLING FACE (facial swelling) and HYPERSENSITIVITY (unspecified allergy). The patient was treated with PREDNISONE at a dose of used for 5 days and DEXAMETHASONE on 26-Mar-2021 at a dose of 1 dosage form. At the time of the report, SWELLING FACE (facial swelling) and HYPERSENSITIVITY (unspecified allergy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication information not provided.